Alice Schwartz Net Worth and Financial Profile
Alice Schwartz is an American billionaire and co-founder of the industrial chemicals and materials company NovaBay Pharmaceuticals, which she helped build through strategic growth and product development focused on antiseptic and antimicrobial solutions. Her net worth is primarily derived from her stake in NovaBay and related private holdings, placing her among the wealthiest self-made women in the United States according to Forbes and other financial rankings. The company's market capitalization and pipeline of products have contributed to the stability and growth of her personal wealth over the years Forbes.
Her financial profile reflects a long-term approach to building value in the healthcare and life sciences sectors, with holdings concentrated in NovaBay Pharmaceuticals and associated private investments. Public records and financial filings indicate that her wealth has remained in the billionaire range, supported by steady revenue streams from NovaBay's core product lines and licensing agreements SEC.
Biography and Career Background
Alice Schwartz co-founded NovaBay Pharmaceuticals with her husband, Ronald Schwartz, and played a central role in shaping the company's mission to develop safe, effective antimicrobial products for both clinical and consumer markets. She holds degrees in science and business, and her career spans decades of leadership in product innovation, regulatory strategy, and corporate governance at NovaBay and related ventures.
Her career trajectory highlights a focus on science-driven entrepreneurship, with NovaBay launching products such as NeutroPhase and other antiseptic lines that address wound care, infection prevention, and hygiene needs. The company has navigated multiple phases of growth, including public listing, pipeline expansion, and strategic partnerships, all under her continued involvement as a co-founder and key decision-maker NovaBay Pharmaceuticals.
Key Companies, Products, and Industry Impact
NovaBay Pharmaceuticals remains the central company associated with Alice Schwartz, with a portfolio centered on antimicrobial and antiseptic technologies used in hospitals, clinics, and consumer settings. The company's products are designed to combat antibiotic-resistant pathogens and support infection control, reflecting a focus on public health and safety NovaBay Pharmaceuticals.
Beyond NovaBay, Alice Schwartz has been involved in private investment and philanthropic activities that align with healthcare innovation and community support. Her influence in the industrial chemicals and life sciences sectors is tied to NovaBay's commercial success and the broader adoption of its antimicrobial solutions in clinical practice Forbes.